TrialJournal of translational medicine2015

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma.

Lisa Zimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.